Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetirizine and Famotidine for COVID-19 Symptoms
NCT04836806Phase 4Withdrawn
- Sponsor
- Emory University
- Start
- Aug 2021
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cetirizine, famotidine in coronavirus disease 2019 (COVID-19), sponsored by Emory University. Planned start Aug 2021; status: withdrawn.
02
Drugs
cetirizinefamotidine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04836806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04836806.